DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Tardif JC, Tanguay JF, L’Allier PL et al.
Effects of the P-selectin antagonist inclacumab on myocardial damage after PCI for non-ST elevation myocardial infarction: results of the SELECT-ACS Trial.
J Am Coll Cardiol 2013;
61: 2048-2055
We do not assume any responsibility for the contents of the web pages of other providers.